Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyphenols | 5 | 2025 | 33 | 3.170 |
Why?
|
| Fruit | 8 | 2025 | 118 | 2.090 |
Why?
|
| Anthocyanins | 8 | 2024 | 22 | 2.060 |
Why?
|
| Phenols | 4 | 2025 | 82 | 1.270 |
Why?
|
| Diet | 4 | 2025 | 564 | 0.870 |
Why?
|
| Terminology as Topic | 2 | 2025 | 67 | 0.730 |
Why?
|
| Fragaria | 2 | 2019 | 15 | 0.680 |
Why?
|
| Biological Availability | 5 | 2025 | 102 | 0.650 |
Why?
|
| Metabolome | 1 | 2019 | 94 | 0.620 |
Why?
|
| Carotenoids | 4 | 2024 | 25 | 0.600 |
Why?
|
| Spinacia oleracea | 3 | 2022 | 7 | 0.550 |
Why?
|
| Glucosides | 2 | 2013 | 16 | 0.500 |
Why?
|
| Flavonoids | 5 | 2022 | 40 | 0.430 |
Why?
|
| Hyperinsulinism | 2 | 2024 | 27 | 0.420 |
Why?
|
| Cross-Over Studies | 5 | 2025 | 230 | 0.330 |
Why?
|
| Bacteria | 2 | 2025 | 210 | 0.320 |
Why?
|
| Cacao | 2 | 2022 | 5 | 0.300 |
Why?
|
| Chlorophyll | 3 | 2022 | 13 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 515 | 0.280 |
Why?
|
| Humans | 22 | 2025 | 50419 | 0.280 |
Why?
|
| Energy Intake | 2 | 2021 | 176 | 0.270 |
Why?
|
| Vascular Stiffness | 3 | 2021 | 20 | 0.270 |
Why?
|
| Digestion | 3 | 2022 | 29 | 0.270 |
Why?
|
| Insulin | 3 | 2024 | 464 | 0.250 |
Why?
|
| Blood Glucose | 3 | 2024 | 447 | 0.250 |
Why?
|
| Hyperglycemia | 2 | 2024 | 81 | 0.250 |
Why?
|
| Diet, High-Fat | 2 | 2024 | 214 | 0.240 |
Why?
|
| Isomerism | 2 | 2025 | 24 | 0.240 |
Why?
|
| Blood Specimen Collection | 1 | 2025 | 35 | 0.230 |
Why?
|
| Capillaries | 1 | 2025 | 50 | 0.230 |
Why?
|
| Insulin Resistance | 2 | 2024 | 267 | 0.230 |
Why?
|
| Plasma | 1 | 2025 | 45 | 0.230 |
Why?
|
| Streptozocin | 1 | 2024 | 24 | 0.230 |
Why?
|
| Veins | 1 | 2025 | 73 | 0.230 |
Why?
|
| Musa | 1 | 2024 | 4 | 0.230 |
Why?
|
| Lipids | 1 | 2025 | 151 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 128 | 0.210 |
Why?
|
| Cardiovascular System | 2 | 2015 | 52 | 0.210 |
Why?
|
| Blood Pressure | 5 | 2021 | 525 | 0.210 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2023 | 28 | 0.210 |
Why?
|
| Young Adult | 4 | 2025 | 4075 | 0.210 |
Why?
|
| Phytotherapy | 3 | 2016 | 46 | 0.190 |
Why?
|
| Male | 12 | 2025 | 25866 | 0.180 |
Why?
|
| Meals | 1 | 2021 | 61 | 0.180 |
Why?
|
| Eating | 1 | 2021 | 158 | 0.180 |
Why?
|
| Adult | 7 | 2025 | 13561 | 0.180 |
Why?
|
| Hydroxybenzoates | 1 | 2020 | 18 | 0.180 |
Why?
|
| Cardiovascular Diseases | 4 | 2016 | 464 | 0.170 |
Why?
|
| Middle Aged | 7 | 2025 | 12579 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 1796 | 0.160 |
Why?
|
| Dietary Proteins | 1 | 2022 | 251 | 0.160 |
Why?
|
| Postprandial Period | 3 | 2024 | 72 | 0.150 |
Why?
|
| Brachial Artery | 1 | 2018 | 16 | 0.150 |
Why?
|
| Tea | 1 | 2018 | 16 | 0.150 |
Why?
|
| Double-Blind Method | 4 | 2023 | 710 | 0.150 |
Why?
|
| Milk | 1 | 2018 | 80 | 0.150 |
Why?
|
| Plant Extracts | 3 | 2022 | 174 | 0.140 |
Why?
|
| Diet, Fat-Restricted | 2 | 2024 | 13 | 0.130 |
Why?
|
| Genotype | 3 | 2024 | 525 | 0.130 |
Why?
|
| Hypertension | 2 | 2012 | 545 | 0.130 |
Why?
|
| Equol | 1 | 2016 | 3 | 0.130 |
Why?
|
| Female | 9 | 2025 | 27053 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 326 | 0.120 |
Why?
|
| Hesperidin | 1 | 2015 | 1 | 0.120 |
Why?
|
| Pulse Wave Analysis | 3 | 2021 | 7 | 0.120 |
Why?
|
| Isoflavones | 1 | 2016 | 89 | 0.120 |
Why?
|
| Beverages | 1 | 2015 | 56 | 0.120 |
Why?
|
| Absorption | 1 | 2013 | 22 | 0.110 |
Why?
|
| Half-Life | 1 | 2013 | 86 | 0.100 |
Why?
|
| Phenotype | 1 | 2016 | 736 | 0.100 |
Why?
|
| Isotope Labeling | 1 | 2013 | 54 | 0.100 |
Why?
|
| Models, Biological | 2 | 2021 | 717 | 0.100 |
Why?
|
| Feces | 1 | 2013 | 138 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2013 | 438 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 285 | 0.090 |
Why?
|
| Cognition | 2 | 2024 | 342 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2012 | 183 | 0.090 |
Why?
|
| Dietary Supplements | 3 | 2023 | 449 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 2231 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 96 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2012 | 216 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 674 | 0.080 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 26 | 0.080 |
Why?
|
| Drug Stability | 1 | 2009 | 35 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2009 | 64 | 0.080 |
Why?
|
| Culture Media | 1 | 2009 | 92 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 167 | 0.080 |
Why?
|
| Pistacia | 1 | 2008 | 3 | 0.080 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2008 | 6 | 0.080 |
Why?
|
| Kinetics | 1 | 2009 | 634 | 0.070 |
Why?
|
| Aged | 5 | 2021 | 9738 | 0.070 |
Why?
|
| Lipoproteins | 2 | 2021 | 40 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2024 | 567 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2019 | 2378 | 0.060 |
Why?
|
| Apolipoproteins | 2 | 2019 | 12 | 0.060 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 41 | 0.060 |
Why?
|
| Colon | 1 | 2025 | 95 | 0.060 |
Why?
|
| Ethylenes | 1 | 2024 | 5 | 0.060 |
Why?
|
| Plant Proteins | 1 | 2024 | 67 | 0.050 |
Why?
|
| Fish Oils | 1 | 2023 | 13 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2023 | 22 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 29 | 0.050 |
Why?
|
| Mice | 2 | 2024 | 5659 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 32 | 0.050 |
Why?
|
| Attention | 1 | 2024 | 165 | 0.050 |
Why?
|
| Animals | 3 | 2024 | 13063 | 0.050 |
Why?
|
| Freeze Drying | 1 | 2022 | 6 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 718 | 0.050 |
Why?
|
| beta Carotene | 1 | 2020 | 9 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 244 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 583 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 694 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 38 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 1431 | 0.040 |
Why?
|
| Camellia sinensis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1601 | 0.040 |
Why?
|
| Vasodilation | 1 | 2018 | 98 | 0.040 |
Why?
|
| Heart Rate | 1 | 2018 | 304 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 341 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2016 | 22 | 0.030 |
Why?
|
| Citrus sinensis | 1 | 2015 | 3 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 1318 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 3712 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 1123 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2012 | 14 | 0.030 |
Why?
|
| Candy | 1 | 2012 | 3 | 0.020 |
Why?
|
| Vaccinium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Apigenin | 1 | 2010 | 6 | 0.020 |
Why?
|
| Time | 1 | 2010 | 27 | 0.020 |
Why?
|
| Catechin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2010 | 31 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 732 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 565 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 39 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 39 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1181 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1451 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1027 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1369 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6453 | 0.010 |
Why?
|